Specialty Pharmacy

No data were presented for treatment-naïve and pretreated adolescents with hepatitis B virus.

Abemaciclib is a CDK4/6 inhibitor being explored in advanced breast cancer.

Investigators believe oral duvelisib may represent an important new treatment option for lymphoma patients.

Competition in HIV drug development affecting stock market.

Clinical trials to begin for an investigational approach to treating glioma.

Inhibiting particle release and infectivity could lead to a cure for HIV-1.

Top news of the day from across the health care landscape.

Merck will present late-breaker abstracts at upcoming IAS 2017 conference.

Cancer diagnoses delayed by an average of 9 days in patients with preexisting conditions.

The Biologics License Application for ibalizumab is under review for the treatment of multidrug resistant HIV-1.

Findings confirm no or negligible placental transfer of anti-TNF drug in women with rheumatoid arthritis.

Messaging based on patient medical records allow for more personalized care in HIV and other conditions.

Top news of the day from across the health care landscape.

The ability of manufacturers to convey the efficacy and safety of a new biosimilar is crucial.

Dutasteride (Avodart) increases blood sugar, A1C, and blood lipids.

The trial is the first to compare Xeljanz alone or in combination with MTX versus adalimumab plus MTX.

Boehringer Ingelheim seeks to launch its biosimilar to Humira.

Reports confirm 10 hepatitis A-related deaths in Detroit area over the past year.

Two KEYNOTE trials were placed on full clinical hold and 1 partial clinical hold.

Abatacept (Orencia) receives approval for third autoimmune condition.

Top news of the day from across the health care landscape.

Research may lead to the development of safer therapies for pregnant women with rheumatoid arthritis.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

The approval greatly expands treatment options for rare inherited blood disorder.

Scientists highlight the potential use of exosomes to detect and treat diseases.

Changing from a biologic to a biosimilar can create insecurity among patients with RA.

Top articles of the week from Specialty Pharmacy Times.

Elevated protein levels may indicate a need for both chemotherapy and surgery for colon cancer.